Repros Therapeutics Inc Stock

Stocks

18-01-26	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
17-12-15	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
17-12-12	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-12-12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
17-12-12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

15-04-02	Apple : Les valeurs à suivre sur les marchés américains
15-04-02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.23%	+1.87%	-0.15%	+28.45%	45.91B
IQVIA HOLDINGS INC.	+0.96%	+5.50%	+45.41%	+29.67%	44.25B
REVOLUTION MEDICINES, INC.	+0.92%	-2.74%	+351.46%	+539.46%	41.99B
BEONE MEDICINES AG	+1.41%	+3.25%	+6.23%	+68.92%	39.58B
CELLTRION, INC.	+1.75%	-1.53%	+12.22%	+41.11%	31.08B
MEDPACE HOLDINGS, INC.	+0.49%	+6.15%	+24.34%	+126.66%	17.21B
ASCENDIS PHARMA A/S	-3.30%	-7.83%	-	-	16.27B
EUROFINS SCIENTIFIC SE	+2.92%	+8.40%	+22.46%	+39.73%	14.96B
ICON PUBLIC LIMITED COMPANY	-0.50%	+3.88%	-1.76%	-34.56%	13.42B
Average	+0.60%	+1.54%	+57.53%	+104.93%	29.41B
Weighted average by Cap.	+0.93%	+0.68%	+72.94%	+127.16%